All News

7th Annual Conference of the Irish Medication Safety Network: Leadership in Medication Safety

Oct 21st 2016: The Irish Medication Safety Network (IMSN) held its 7th annual conference on Friday 21st October at Farmleigh House in Dublin’s Phoenix Park. Entitled ‘Leadership in Medication Safety’, the conference was attended by healthcare professionals, representatives of relevant state and professional bodies, and patient representatives.

 

Speakers included Mr. Sean Egan, Acting Head of Healthcare Regulation HIQA and Ms. Ciara Kirke, Clinical Lead Safermeds, HSE Quality Improvement Division. The conference also heard the experience of three Chief Pharmacists working in dedicated medication safety facilitator roles in acute hospitals- Dr. Eileen Relihan, Ms. Deirdre Lenehan and Ms. Anne Marie Cushen. 

The focus of this year’s event was Leadership in Medication Safety and delegates heard of HIQA’s plans to commence a programme of monitoring in public acute hospitals in the area of Medication Safety. The aim of the monitoring programme is to assess the systems around safe medication practices, identify opportunities for improvement and models of good practice to reduce risks to patients.

 

Speaking at the conference, Mr Paul Tighe, Chairperson of the IMSN and Chief Pharmacist at St. Vincent’s University Hospital, commented that “The vision of the IMSN is to encourage safer medication use in Irish public and private hospitals. The importance of the leadership role of the Medication Safety Facilitator as part of hospital governance structures for medication safety is evident”. 

Ms Ciara Kirke, Clinical Lead Safermeds, HSE Quality Improvement Division described the first Safermeds quality improvement collaborative. This collaborative model has recently commenced with hospitals to support them in assessing in-patients at risk of developing hospital-acquired blood clots and choosing the appropriate preventative treatment.

 

Notes to Editors

 

 

Established in 2007, the IMSN is a voluntary network of independent pharmacists working in the acute healthcare sector with a special interest in medication safety. 

 

The network has representation from all major hospitals in the country, both public and private, reaching over 50 acute health care facilities in Ireland.

 

The IMSN’s principal aim is to improve patient safety with regard to the use of medicines through improved sharing of information throughout the acute healthcare system and the adoption of national and global initiatives to help minimise risks to patients.

 

To this end, it has published several alerts, guidelines and briefing documents, available on its website, www.imsn.ie .  It also liaises with relevant state bodies and working groups to develop national patient safety initiatives. 

 

Its members are active in developing patient safety initiatives within Irish acute hospitals and are also involved with Irish universities in delivering medication safety education modules as part of undergraduate medical, nursing and pharmacy degree courses and post-graduate programmes.

 

Ends

 

 

For further information:

 

Geraldine Creaton, IMSN Correspondence Secretary at This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medication safety an important priority for Irish health services

Press Release

Friday 9th October, 2015, Pillar Room, Rotunda Hospital, Dublin 1

The Irish Medication Safety Network (IMSN), with the support of the HSE and the Rotunda Hospital, hosted two events this week to improve medication safety.

Medication safety is an important priority for the Irish health services.  Internationally it is estimated that one medication error occurs per hospital in-patient per day, translating to over 3 million medication errors in Irish public hospitals per year.  A small proportion of errors result in patient harm, but all are potentially preventable.

A two day Medication Safety Intensive course for over 100 participants was delivered by  the Institute for Safe Medication Practices (ISMP), a US not-for-profit organisation renowned as world experts in the field of medication safety.  It is the first time that the course has been run in Europe and ISMP translated their very highly rated course to the Irish setting.

The course, attended by pharmacists, nurses, doctors and risk managers from Irish hospitals, was followed today by a one day  National Medication Safety Summit, which brought together 250 healthcare professionals, health service leaders and representatives from bodies connected to medication safety and Irish and international speakers. 

Speaking at the summit , Mr Paul Tighe, Deputy Chair of the IMSN and Chief Pharmacist at St. Vincent’s University Hospital, commented that “The IMSN is striving to improve awareness about medication safety issues and to provide guidance to healthcare staff who are working to minimise harm arising from medication errors. We are delighted that our colleagues from the ISMP are here to share expertise and provide guidance on how systematic approaches to medication safety have been structured internationally. Staff from hospitals around the country have been provided with training on effective risk reduction strategies.  I have no doubt Irish patients will benefit from the knowledge acquired over the past few days.”

Ms Ciara Kirke, Clinical Lead of the National Medication Safety Programme, HSE Quality Improvement, said that medication safety is a priority for the HSE and the organisation is embarking on a new programme to tackle the issue of patient harmed associated with medicines.  “Ireland is uniquely poised to bring about improved medication safety.  We have examplars of best practice throughout the country, dedicated professionals focussed on medication safety, a wealth of high-quality research and a will to collaborate and improve.  The HSE QID is delighted to support this course and summit to bring about shared understanding of the problem and how we can design systems and use information to minimise the risk of error and patient harm.  The HSE QID Medication Safety Programme looks forward to working with Irish hospitals in an improvement partnership to further the impact of this worthwhile initiative”

Dr Allen Vaida, Executive Vice President of the ISMP, said today, “we are delighted to share our experiences and recommendations with healthcare practitioners in Ireland to advance medication safety for patients in Ireland. We want to thank and commend IMSN, HSE, and the other government agencies and organizers for their collaboration and enthusiasm to make this program possible.  

Dr Brian Cleary, Rotunda Hospital Chief Pharmacist and RCSI Honorary Clinical Associate Professor, said, “The IMSN aimed to draw attention to the problem of medication errors this week and to ensure that effective risk reduction strategies are implemented to improve medication use processes. The Irish health services need to learn from international experience and ensure that  no patient is harmed by preventable medication errors. Effective risk reduction strategies applied at a national level will help to achieve this.”

Notes to Editors

About the Irish Medication Safety Network (IMSN):

The IMSN is a voluntary and independent group of hospital pharmacists, whose principal aim is to improve patient safety with regard to the use of medicines through collaboration, shared learning and action. Established in 2006, the network develops guidelines, protocols and alerts on medication safety concerns which it distributes across all public and private Irish hospitals, in addition to hosting annual conferences.

Website: www.imsn.ie                   Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

About the Institute of Safe Medication Practices (ISMP):

The Institute for Safe Medication Practices (ISMP), is a US non-profit organization devoted entirely to medication error prevention and safe medication use. ISMP represents over 35 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. The organization is known and respected worldwide as the premier resource for impartial, timely, and accurate medication safety information.

Website: www.ismp.org

About the Health Services Executive Quality Improvement Division (HSE QID):

The division led by Dr. Philip Crowley was established in January 2015. The mission of the QID team is to provide leadership by working with patients, families and all who work in the health system to innovate and improve quality and safety of care by championing, educating, partnering and demonstrating quality improvement. Our vision is working in partnership to create safe quality care.

ENDS

Media Contact:   HSE Press Office 01 6352840

Health Minister Congratulates Irish Medication Safety Network

IMSN conference hears pain management still problematic in the 21st century

Minister for Health Leo Varadkar has congratulated the Irish Medication Safety Network for its 'invaluable' role in creating a 'patient safety first' culture in Ireland.

Opening the IMSN's fifth annual conference at Farmleigh House in the Phoenix Park, Mr Varadkar praised the IMSN and said putting patient safety first was now embedded in his Department's philosophy.

Group With Minister

He said: 'The work of this network in providing guidance, for example on Potassium, has been invaluable and is to be commended. I and my colleagues in the DOH are very grateful.'

Mr Varadkar also reminded the audience that sometimes it's not the quality of medicines that put patients at risk but the processes involved – prescribing, dispensing or administering them.

He added: 'The 2008 Patient Safety Report provides a roadmap for a national culture of patient safety and outlines specific measures including medication safety.'

The IMSN continued its highly successful series of annual conferences. Last Friday's was the fifth to take place at Farmleigh House in Dublin's Phoenix Park.

This focus of year's event, Pitfalls in Pain Management Therapeutics and Management, was on pain in different populations and clinical situations, highlighting treatment risks and how to address them.

It was addressed by specialists in acute pain, palliative medicine, and paediatrics. Speakers included Dr Conor Hearty, Dr Lucy Balding and Cliona Hayden, Dr Branislav Mislovic and Oisin hAlmhain.

The conference was attended by healthcare professionals, representatives of relevant state and professional bodies, and patient representatives, who heard that safety issues still persist with pain management in the 21st century.

Speakers emphasised that it is essential to know both the pain type and the patient with whom you're dealing, and highlighted the importance of multimodal treatment, individual treatment plans and flexibility.

For further information:

Niamh O'Hanlon, Vice-chair Irish Medication Safety Network

This email address is being protected from spambots. You need JavaScript enabled to view it.

Notes for editors:

A key aim of the IMSN is to have a strong medication safety culture enmeshed in the Irish healthcare system, supported by national and local policy.

Established in 2007, the IMSN is a voluntary network of independent pharmacists and other specialists working in the acute healthcare sector with a special interest in medication safety.

The network has representation from all major hospitals in the country, both public and private, reaching over 50 acute health care facilities in Ireland.

The IMSN's principal aim is to improve patient safety with regard to the use of medicines through improved sharing of information throughout the acute healthcare system and the adoption of national and global initiatives to help minimise risks to patients.

To this end, it has published several alerts, guidelines and briefing documents, available on its website, www.imsn.ie. It also liaises with relevant state bodies and working groups to develop national patient safety initiatives.

Its members are active in developing patient safety initiatives within Irish acute hospitals and are also involved with Irish universities in delivering medication safety education modules as part of undergraduate medical, nursing and pharmacy degree courses and post-graduate programmes.

Guidelines
Article Count:
5
Briefing Documents
Article Count:
5
Publications
Article Count:
3
Events
Article Count:
7
Alerts
Article Count:
12